IgG4-Related and Inflammatory Diseases
Moving in Gastroenterology, Annals of the Rheumatic Diseases, JAMA, New England Journal of Medicine, American Journal of Respiratory and Critical Care Medicine, Annals of Neurology, JAMA Neurology and Kidney International.
- Moved, week to 17 Nov 2026
- 0
- Papers in 60 days
- 18
Rebuilt
Moved this week
Nothing in this topic has moved yet this week.
Latest in IgG4-Related and Inflammatory Diseases
Newest first · last 60 days
AI summary · may contain errors
A consensus IgG4-related disease treatment guideline was developed from 28 graded statements, reaching agreement on 22 statements by 52 physicians.
AI summary · may contain errors
Serum CCL19 is elevated in IgG4-related disease and decreases during treatment-induced remission, distinguishing active disease from remission and tracking relapse dynamics.
- 2 cites
AI summary · may contain errors
NMU-expressing IGHV1-69+ IgG4+ plasma cells were identified as a previously unrecognized pathogenic subset linked to IgG4-related disease recurrence during rituximab-treated longitudinal follow-up.
- Open access
- 2 cites
AI summary · may contain errors
Add-on intravenous immunoglobulin (IVIG) given at 0, 4, and 8 weeks improves myositis activity at week 12 in newly diagnosed adult idiopathic inflammatory myopathies, raising Total Improvement Score to 60.0 vs 42.5 with P=.01.
- Open access
AI summary · may contain errors
In a double-blind randomized trial in France for eosinophilic granulomatosis with polyangiitis, rituximab maintenance did not extend remission duration versus azathioprine (91.1 vs 96.0 weeks; P=.38).
AI summary · may contain errors
HtpG-high-expressing Escherichia coli is enriched in chronic pancreatitis patients and its adherence/colonization promotes pancreatic fibrosis in mice.
AI summary · may contain errors
Chronic pancreatitis involves progressive inflammation and fibrosis, with diagnosis often occurring at advanced stages marked by ductal dilatation or calcification.
- 1 cites
AI summary · may contain errors
Obexelimab significantly prolongs time to disease flare and reduces glucocorticoid exposure in patients with IgG4-related disease.
- 2 cites
Browse JClub
Journals this month
- bioRxiv6386
- medRxiv1756
- PNAS556
- JAMA352
- Sci Adv330
- Cell Rep314
- Environ Res213
- BMJ209
- EHJ206
- Nat Commun172
- NAR172
- Plant Cell Environ167
- Environ Pollution153
- Science152
- NEJM148
- New Phytol145
- Curr Biol130
- Nature127
Topics moving, week to 17 Nov 2026
- Single-cell and spatial transcriptomics10
- Gut microbiota and health6
- CAR-T cell therapy research6
- Pancreatic and Hepatic Oncology Research5
- Genomics and Chromatin Dynamics5
- Inflammatory Bowel Disease5
- Lung Cancer Treatments and Mutations5
- Antibiotic Resistance in Bacteria5
- Genomics and Phylogenetic Studies4
- Lipoproteins and Cardiovascular Health4
By field
- General Science & Medicine22
- Clinical Medicine25
- Cardiology & Vascular Biology12
- Endocrinology & Metabolism10
- Gastroenterology & Hepatology7
- Public & Global Health4
- Cell & Molecular Biology30
- Immunology & Inflammation14
- Neuroscience14
- Psychiatry & Mental Health8
- Genomics & Bioinformatics29
- Pharmacology & Drug Discovery5
- Microbiology & Mycology34
- Oncology22
- Ecology & Evolution5
- Protected Cropping & Horticultural Science5
- Plant Physiology & Photobiology19
- Student Research1
